lobbying_activities: 1196291

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1196291	d82ba2eb-0a4e-4f08-bdae-a7e34dc8565f	Q4	THE DUBERSTEIN GROUP INC.	12675	PFIZER INC.	2011	fourth_quarter	PHA	Reimported drugs from Canada - HR 2112, Consolidated and Further Continuing Appropriations Act, 2012. Counterfeit drug penalty enforcement act - S 1886, Counterfeit Drug Penalty Enhancement Act of 2011. Patent and generic drugs - Congressional investigation re this issue.	HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)	100000		0	0	2012-01-19T14:20:47-05:00